Futures down 15 points as overseas markets continue to fall

Published 15-OCT-2020 09:55 A.M.

|

3 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

The index (XJO) came off 17 points on Wednesday to close at 6179 points, a decline of 0.3%.

In line with overseas markets, it was predominantly travel and financial stocks that led the market lower.

Strong performances from some tech and healthcare stocks helped to offset this downward pressure.

However, it could be a different story today because it was consumer discretionary stocks that felt the pinch overnight in the US with prominent casualties being Walmart Inc, Nike Inc and Home Depot, while services companies such as Honeywell International and Inc and Caterpillar Inc made good gains and Boeing recovered some of the previous day’s losses.

The ASX SPI200 index is down 15 points to 6146 points, but this could be a little optimistic with real concerns surrounding an acceleration of COVID cases in Europe, combined with a lack of intent by the US government to instigate an interim stimulus package placing a significant drag on equities markets.

Similar issues will come to the fore today in Australia with monetary policy likely to be the key areas of attention when Reserve Bank of Australia governor Philip Lowe delivers his address.

With employment figures also to be released today, we could see domestic macroeconomic factors emerge as key market drivers.

Scanning overseas markets, the FTSE 100 started in the black but unravelled throughout the day setting the tone for lacklustre trading in mainland Europe and providing a backdrop of negative sentiment as US markets opened.

The FTSE 100 came off 0.6% to close at 5935 points, while the DAX edged up slightly and the CAC 40 gave up a meagre six points.

In the US, markets were up slightly in morning trading but trended down across the board during the afternoon with the NASDAQ being hardest hit.

It finished down 95 points or 0.8% to 11,768 points, while the Dow fell 166 points or 0.6% to close at 28,514 points.

Keep an eye on oil stocks

Oil was the late mover on the commodities front with the Brent Crude Oil Continuous Contract surging from about US$42.20 per barrel to US$43.32 in afternoon trading.

This was in response to comments made by Russia’s energy minister Alexander Novak that the OPEC+ alliance would still be able to gradually ease production cuts from January as previously planned.

Gold pushed back through US$1900 per ounce, and it is currently hovering just above that mark.

Iron ore came off 1% to close at US$119.50 per tonne.

Aside from nickel, there was little movement amongst base metals.

However, nickel recorded a significant milestone, regaining the US$7.00 per pound mark, a level it only touched briefly in late August/early September.

Given that US$8 per pound is a long-term high for the metal, it is in extremely strong shape with potential for more upside if manufacturing activity continues to improve.

The Australian dollar was virtually unmoved overnight at US$0.716, but this could change today in response to Reserve Bank of Australia commentary.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X